David Adlam

Showing 1-3 of 3 articles

Coronary interventions

Patient-oriented composite endpoints and net adverse clinical events with ticagrelor monotherapy following percutaneous coronary intervention: insights from the randomised GLOBAL LEADERS trial

Serruys P, Tomaniak M, Chichareon P, Modolo R, Kogame N, Takahashi K, Chang C, Spitzer E, Walsh S, Adlam D, Hildick-Smith D, Édes I, van de Harst P, Krackhardt F, Tijssen J, Rademaker-Havinga T, Garg S, Steg P, Hamm C, Jüni P, Vranckx P, Onuma Y, Verheugt F

December 20, 2019 | 10.4244/EIJ-D-19-00202

Coronary interventions

Long-term follow-up of spontaneous coronary artery dissection treated with bioresorbable scaffolds

Macaya F, Salinas P, Gonzalo N, Camacho-Freire SJ, Jackson R, Massot M, Ortas-Nadal MR, Sanchez Recalde A, Diaz-Fernandez J, Moreu J, Adlam D, Escaned J

January 18, 2019 | 10.4244/EIJ-D-18-00519

Editorial on: “Characteristics of extension and de novo recurrent spontaneous coronary artery dissection”

Adlam D, Wood A, Al-Hussaini A

December 8, 2017 | 10.4244/EIJV13I12A220

1

Latest news

Challenging TAVI anatomies, risk prediction for PCI of CTOs, antithrombotic strategies, and more

NEW ahead of print: Difference of thrombogenicity in durable polymer DES

Representative confocal microscopic images using immunofluorescent staining

Cardiocerebral Continuum in Cognitive Function After TAVI

New Update: CULPRIT, NOBEL, IVUS-XPL, SAFARI-STEMI

(supported by Biotronik)

February 14, 2020

Guidance Papers

Guidelines, consensus & position papers

Novel Approaches to Guide Revascularization in STEMI & Multivessel CAD

This week's JAA's: BASILICA technique & Intravascular lithotripsy for left main disease

Coronary

Valvular disease

Heart failure

Peripheral

Hypertension

Stroke